About Protein phosphatase 1J
Protein phosphatase 1J (PPM1J) is a protein
from Homo sapiens identified by UniProt accession
Q5JR12, 505 residues long.
MolForge cross-references it against 0 known binders and
44 disease associations.
Target properties
| Protein name | Protein phosphatase 1J |
| UniProt accession | Q5JR12 |
| Gene | PPM1J |
| Organism | Homo sapiens |
| Length | 505 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (44)
Diseases linked to this target (Open Targets).
- glomerular filtration rate · score 0.42
- creatinine measurement · score 0.40
- appendicular lean mass · score 0.35
- neurodegenerative disease · score 0.29
- genetic disorder · score 0.12
- aspartate aminotransferase measurement · score 0.08
- intraocular pressure measurement · score 0.08
- bone density · score 0.07
- sex hormone-binding globulin measurement · score 0.07
- body height · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5JR12-F1 | alphafold | PREDICTED | 83.87 | — |
Amino-acid sequence (505 residues)
MLNRVRSAVA HLVSSGGAPP PRPKSPDLPN AASAPPAAAP EAPRSPPAKA GSGSATPAKA VEARASFSRP TFLQLSPGGL RRADDHAGRA VQSPPDTGRR LPWSTGYAEV INAGKSRHNE DQACCEVVYV EGRRSVTGVP REPSRGQGLC FYYWGLFDGH AGGGAAEMAS RLLHRHIREQ LKDLVEILQD PSPPPLCLPT TPGTPDSSDP SHLLGPQSCW SSQKEVSHES LVVGAVENAF QLMDEQMARE RRGHQVEGGC CALVVIYLLG KVYVANAGDS RAIIVRNGEI IPMSREFTPE TERQRLQLLG FLKPELLGSE FTHLEFPRRV LPKELGQRML YRDQNMTGWA YKKIELEDLR FPLVCGEGKK ARVMATIGVT RGLGDHSLKV CSSTLPIKPF LSCFPEVRVY DLTQYEHCPD DVLVLGTDGL WDVTTDCEVA ATVDRVLSAY EPNDHSRYTA LAQALVLGAR GTPRDRGWRL PNNKLGSGDD ISVFVIPLGG PGSYS
Explore Protein phosphatase 1J with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets